Secondary Logo

Journal Logo

November 13, 2012 - Volume 26 - Issue 17
pp: 2121-2265

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice

Dash, Prasanta K.; Gendelman, Howard E.; Roy, Upal; More

AIDS. 26(17):2135-2144, November 13, 2012.

Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples

Choi, Robert Y.; Levinson, Pauline; Guthrie, Brandon L.; More

AIDS. 26(17):2155-2163, November 13, 2012.

Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA

Feeney, Eoin R.; van Vonderen, Marit G.A.; Wit, Ferdinand; More

AIDS. 26(17):2165-2174, November 13, 2012.

Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM

Wentzensen, Nicolas; Follansbee, Stephen; Borgonovo, Sylvia; More

AIDS. 26(17):2185-2192, November 13, 2012.


Ribavirin and abacavir drug interaction in HIV–HCV coinfected patients: fact or fiction?

Solas, Caroline; Pambrun, Elodie; Winnock, Maria; More

AIDS. 26(17):2193-2199, November 13, 2012.

Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis

Houlihan, Catherine F.; Larke, Natasha L.; Watson-Jones, Deborah; More

AIDS. 26(17):2211-2222, November 13, 2012.


Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

Berenguer, Juan; Alejos, Belén; Hernando, Victoria; More

AIDS. 26(17):2241-2246, November 13, 2012.